Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives ...

Columbus Community Hospital will be hosting Diabetes Awareness Day from 4:30 to 7 p.m. Thursday, Oct. 2, in the hospital’s first-floor conference center. The event will include cooking demonstrations, ...

A new study from Duke University School of Medicine is challenging long-standing views on blood sugar regulation—and pointing to a surprising new ally in the fight against type 2 diabetes. Using mass ...

In this phase 3, multinational, randomized, double-blind trial, we examined the safety and efficacy of once-daily orforglipron at doses of 6 mg, 12 mg, or 36 mg, as compared with placebo (assigned in ...

A new study from Duke University School of Medicine is challenging long-standing views on blood sugar regulation - and pointing to a surprising new ally in the fight against type 2 diabetes. Published ...

The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at helping individuals lose weight. However, a new population-wide study ...

Scientists have been surprised by a recent discovery that says under special conditions, some of your body cells in the pancreas can produce the hormone GLP-1, which is mimicked by popular diabetes ...

Wegovy is a prescription injection that’s used along with exercise and a reduced-calorie diet for weight loss in certain adults and children. This drug works by reducing appetite and slowing down the ...

Mounjaro (tirzepatide) is a prescription medication used with diet and exercise to help adults with type 2 diabetes manage blood sugar levels. Mounjaro comes as an injection given under the skin.